Pregnancy outcomes and it’s determinants at a tribal hospital in south India– A prospective cohort study (PREDICT)
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2022 - Ongoing
Project Lead
Dr. Denis Xavier
Authors
PI- Dr. Denis Xavier, Co-I : Dr. Padmini Devi , Dr Deepa. S, Dr. Ryan Fernandez
Project Status
ongoing